Research Projects

This database contains information on EU funded dementia research projects, undertaken since 2007. It is the product of a mapping exercise of European funding programmes for dementia research conducted by Alzheimer Europe in 2020. This database is not an exhaustive resource of information. It contains information about dementia research projects that are funded by European programmes including FP7, H2020, IMI, JPND, AAL and the third EU Health programme. The mapping exercise and database were expanded in 2025, to include projects funded under Horizon Europe (including IHI). For these projects, the database reports the maximum contribution from the European Commission rather than the total project budget, so funding figures may not be directly comparable across all entries.
For an overview of projects, Alzheimer Europe is involved in, visit: https://www.alzheimer-europe.org/our-work/current-work

Filters

(Clear all)

Molecular physiology of nerve terminal bioenergetics

SynaptoEnergy

Synaptic transmission is an extremely energetically-demanding process that consumes 75% of the energy required for brain function. However, it remains poorly understood how synapses guarantee the necessary ATP levels required for neurotransmission. While our understanding of the metabolic pathways for ATP production is vastly detailed, very little...

Funding Programme
Start Date
End Date
Total Funding
€ 1 494 605
European Countries Involved

Molecular Structure and Engineering of Synaptic Organizer Proteins in Health and Disease

SynLink

Synapses are the specialized cellular junctions that form the basic units of communication between neuronal cells. Given the variety of network-dependent functions that synapses need to support, a fundamental question is how their properties are specified at the molecular level. Membrane-anchored and soluble “synaptic organizer proteins” form...

Funding Programme
Start Date
End Date
Total Funding
€ 1 499 903
European Countries Involved

Mosaic loss of chromosome Y (LOY) in blood cells - a new biomarker for risk of cancer and Alzheimer’s disease in men

DIALOY

My recent discoveries show that mosaic loss of chromosome Y (LOY) in peripheral blood is associated with increased risks of cancer and Alzheimer’s disease (AD). These conditions are responsible for >50% of morbidity/mortality in aging men. More than 15% of men older than 70 show some degree of LOY and these men survive on average only half as long...

Funding Programme
Start Date
End Date
Total Funding
€ 1 525 000
European Countries Involved

MRI based mapping of microscopic brain composition in a mouse model of Alzheimer’s disease

uImaging

This project aims to establish a neuroimaging framework which informs about microscopic brain composition and apply it to study neurodegeneration in a genetic mouse model of Alzheimer’s disease (AD). AD is the most common cause of dementia, characterized by progressive neurodegenerative changes leading to a gradual cognitive loss and memory...

Funding Programme
Start Date
End Date
Total Funding
€ 159 815
European Countries Involved

Multi-omics Interdisciplinary Research Integration to Address DEmentia diagnosis

MIRIADE

Dementia is currently diagnosed largely based on cognitive decline, while pathology starts years before symptom onset. To make progress in the development of effective drugs for dementia, there is an urgent need for biomarkers to enable precision health: for early and specific diagnosis and objective monitoring of disease progression. With its...

Funding Programme
Start Date
End Date
Total Funding
€ 4 034 565

Multi-sensory experiences for in-home therapy and entertainment

MOMENTS

Multi-Sensory Environments (MSEs) is a discipline of occupational therapy that helps treat cognitive and sensory deficiencies (in memory, attention, social interaction…) of people with developmental disabilities, physical disabilities, neuro-degenerative diseases and or brain-injuries. These conditions which include autism, dementia, Down syndrome...

Funding Programme
Start Date
End Date
Total Funding
€ 71 429
European Countries Involved

Multiregional rtfMRI Neurofeedback for the Prevention of Alzheimer's Disease

NPAD

This project aims at predicting early cognitive decline using a neurofeedback performance endophenotype based on realtime functional magnetic resonance imaging in a population at risk for Alzheimer’s Disease (AD). It has been proven that AD biomarkers change decades before the development of symptoms. In addition, there is a lack of robust...

Funding Programme
Start Date
End Date
Total Funding
€ 158 122
European Countries Involved

Multitarget compounds with therapeutic potential against Alzheimer disease: Design and in vitro studies

CHELALZ

This fellowship will provide a prolific researcher with an internationally competitive, multi-disciplinary research training at the Chemistry/Biology interface in an EU leading Bioinorganic chemistry team, preparing her to obtain her goal of a faculty position in the EU and her own research team in Medicinal Chemistry. She will develop novel anti...

Funding Programme
Start Date
End Date
Total Funding
€ 170 122
European Countries Involved

Nano-diamond tracers for MRI molecular imaging

NDI

Molecular imaging is the current standard of care for the diagnosis (staging) of cancer, the evaluation of cancer treatment effectiveness, and is generating evidence as the best predictor for earlier diagnosis of Alzheimer’s disease. Molecular imaging differs from traditional imaging in that probes known as biomarkers are used to help image...

Funding Programme
Start Date
End Date
Total Funding
€ 147 500
European Countries Involved

Nanoscale Analytical Methods to gain insight into the Initiation of Short-Term Memory

NAMISTMem

The aim of this project is to develop novel nano-bioanalytical methodologies to explore a molecular paradigm for the initiation of short-term memory (STM) based on exocytosis events. Despite the vital role in neural disorders such as Alzheimer’s disease, the molecular mechanisms of the initial step in STM formation is still mostly a mystery...

Funding Programme
Start Date
End Date
Total Funding
€ 185 857
European Countries Involved

Navigation of a mind-space. The spatial organization of declarative knowledge

NOAM

Your brain is among the most complex existing systems, and it processes every second an amazing amount of data. The most amazing thing, however, is that you get to know some of it. Declarative knowledge, meaning the portion of knowledge that we can consciously access and manipulate, is one of the most enduring mysteries of the human mind. How did...

Funding Programme
Start Date
End Date
Total Funding
€ 1 498 644
European Countries Involved

Neural mechanisms, functional roles and pathophysiological relevance of human grid cell-like representations

GridRepresentations

The entorhinal cortex contains grid cells, a major cell type underlying spatial navigation. At the same time, it is amongst the first areas of the brain to be affected by Alzheimer’s disease (AD). In humans, grid cell-like representations (GCLRs) have been proposed as a network-level signature of grid cells that can be recorded non-invasively via...

Funding Programme
Start Date
End Date
Total Funding
€ 1 999 243
European Countries Involved
 
Acknowledgement
Alzheimer Europe's database on research projects was developed as part of the 2020 Work Plan which received funding under an operating grant from the European Union’s Health Programme (2014–2020).